Skip to content

Efficacy and safety of PRP, PRF, CGF in the treatment of female pattern hair loss

Efficacy and safety of PRP, PRF, CGF in the treatment of female pattern hair loss

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081007
Enrollment
Unknown
Registered
2024-02-20
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female pattern hair loss

Interventions

PRF group:PRF
CGF group:CGF

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged 18-45 years; 2. Patients with a definite diagnosis of FPHL and Sinclair classification of II or III; 3. No topical hair growth medications or other topical treatments within 3 months prior to treatment; 4. No systematic use of drugs with hair regrowth effects in the 3 months prior to treatment; 5. Those who have good compliance and can participate in regular follow-up visits

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; menopausal women; women with menstrual disorders; 2. Other types of hair loss such as alopecia areata, telogen effluvium, and hair loss caused by ringworm; 3. Inflammation of the scalp, trauma, and other conditions that are not suitable for harvesting hair follicles; 4. Accompanied by other serious illnesses such as infections, tumors, and psychiatric symptoms; 5. Those who are participating in other clinical trial studies; 6. Those whom the researcher considers unsuitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
hair density and hair shaft diameter under dermoscope;

Secondary

MeasureTime frame
Sinclair's stage change;7-point global-assessment scale;patients' satisfaction;the women's androgenetic alopecia quality of life questionnaire;Scalp Oil Determination;

Countries

China

Contacts

Public ContactFenglin Zhuo

Beijing Friendship Hospital, Capital Medical University

zflsunny@hotmail.com+86 159 1089 5068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026